本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

GT Biopharma Inc.

2.28
-0.0019-0.08%
盤後2.350.0700+3.07%16:00 EDT
成交量:1.09萬
成交額:2.51萬
市值:578.30萬
市盈率:-0.33
高:2.32
開:2.30
低:2.28
收:2.28
資料載入中...
2025/04/14

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/04

重要事件披露

Form 8-K - Current report
2025/03/12

SEC問詢函

Form CORRESP - Correspondence
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/07

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/27

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/27

重要事件披露

Form 8-K - Current report
2024/12/23

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/28

重要事件披露

Form 8-K - Current report
2024/11/21

重要事件披露

Form 8-K - Current report
2024/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/16

重要事件披露

Form 8-K - Current report
2024/08/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/27

SEC問詢函

Form CORRESP - Correspondence
2024/06/27

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/20

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/07

重要事件披露

Form 8-K - Current report